Zydus receives final approval from USFDA for Methenamine Hippurate Tablets USP, 1 gram
Ahmedabad, India, 12 March, 2025Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) hasreceived final approval from the United States Food and Drug Administration (USFDA) to manufactureMethenamine […]
LANXESS: Longer-lasting tires through sustainable antioxidant
Mumbai, March 12, 2025 – LANXESS’ new rubber additive VulkanoxHS Scopeblue supports tire manufacturers in producing moresustainable, longer-lasting tires and in achieving their sustainabilitygoals. The antidegradant from the specialty chemicals […]
Bridging the Gap in Diabetes Care: CORONA Remedies introduces affordable solution of Empagliflozin
CORONA Remedies Limited, (formerly known as CORONA Remedies Private Limited) has launched its genericversion of Empagliflozin introduced under the brand name “Empabite & it extensions” a SGLT-2 inhibitor, forType 2 […]
Refining high-purity battery metals with Lewatit MK51 from LANXESS
LANXESS is offering a new solution for the rapidly growing battery industry. The Lewatit MK 51 ion exchange resin from LANXESS selectively removes boron from metal concentrates, thus enabling the extraction of high-purity raw materials for use in batteries.
12th Vinyl India Business Summit & Exhibition to Unite the Global PVC & CPVC Industry in Mumbai
Mumbai, 11th March 2025 India – The 12th edition of Vinyl India, the World’s Leading PVC & CPVC Business Summit & Exhibition, organized by ElitePlus++ Business Services, will take place […]
Glenmark Pharma Expands Cardiometabolic Portfolio with the Launch of Empagliflozin and its Fixed-Drug Combinations in India
– Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M. – Studies have demonstrated several benefits of Empagliflozin, including effectively […]